2023
DOI: 10.3389/fmed.2023.1145487
|View full text |Cite
|
Sign up to set email alerts
|

Systematic analysis and prediction for disease burden of ovarian cancer attributable to hyperglycemia: a comparative study between China and the world from 1990 to 2019

Abstract: BackgroundOvarian cancer is one of the most common female malignancies worldwide, and metabolic factors, such as hyperglycemia, are becoming potential risk factors. This study aimed to analyze the disease burden and its changing trend of ovarian cancer attributable to hyperglycemia in the Chinese population from 1990 to 2019.MethodsUsing the data released by the Global Burden of Disease study 2019 (GBD 2019), we analyze the disease burden of ovarian cancer attributable to hyperglycemia in Chinese from 1990 to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…The carcinogenicity of these elements is assessed by quantifying the Excess Lifetime Cancer Risk (ELCR), which is determined using Eq. ( 4 ) 29 , 30 : where ELCR excess lifetime cancer risk, CDI chronic daily intakes (mg/kg/day), SF cancer slope factor (mg/kg/day).…”
Section: Methodsmentioning
confidence: 99%
“…The carcinogenicity of these elements is assessed by quantifying the Excess Lifetime Cancer Risk (ELCR), which is determined using Eq. ( 4 ) 29 , 30 : where ELCR excess lifetime cancer risk, CDI chronic daily intakes (mg/kg/day), SF cancer slope factor (mg/kg/day).…”
Section: Methodsmentioning
confidence: 99%
“…In 2020, 314,000 new ovarian cancer patients were diagnosed, and 207,000 death cases occurred worldwide. It is estimated that there will be 446,000 new cases and 314,000 deaths in 2040 [2]. The histological subtypes of epithelial ovarian cancer are low-and high-grade serous, clear cell, mucinous, and endometrioid tumors.…”
Section: Introductionmentioning
confidence: 99%